Beta Drugs Limited (BETA)

Volume: 1,80,651Avg Vol 1W: 44,880Avg Vol 1M: 30,38852W Range:₹990.1₹2,000

₹1,871.8▼ 0.98%

Key Ratios

Market Cap₹1,795 Cr

Current Price₹1,871.8

Previous Close₹1,890.3

High / Low (52w)₹2,000 / ₹990.1

Volume1,80,651

Avg Vol (1W)44,880

Avg Vol (1M)30,388

Stock P/E45.35

Book Value₹241.39

Dividend Yield0%

ROE16.95%

ROA8.37%

Revenue (TTM)—

Revenue Growth22.54%

Profit Margin10.78%

Total Debt₹127 Cr

Shares Outstanding1 Cr

Face Value₹10

EPS (TTM)₹8.93

P/B5.56

Debt / Equity0.6

50 DMA₹1,381.73

200 DMA₹1,520.53

Day change-0.98%

Price Chart

₹1,871.8▲ 4.57% · 1Y

2025-06-17

2026-06-12

20-day avg volume: 31K shares

Pros

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Mar 2025	Dec 2024
Revenue	₹94 Cr	₹87 Cr	₹103 Cr	₹94 Cr	₹88 Cr
EBITDA	₹16 Cr	₹15 Cr	₹20 Cr	₹18 Cr	₹16 Cr
Net Profit	₹9 Cr	₹9 Cr	₹12 Cr	₹9 Cr	₹9 Cr
EPS	8.93	8.4	12.1	9.4	9.31

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹369 Cr	₹297 Cr	₹228 Cr	₹185 Cr	₹117 Cr	₹91 Cr
EBITDA	₹69 Cr	₹52 Cr	₹43 Cr	₹36 Cr	₹18 Cr	₹15 Cr
Net Profit	₹42 Cr	₹36 Cr	₹31 Cr	₹25 Cr	₹12 Cr	₹9 Cr
EPS	42.02	37.9	31.95	25.82	12.2	9.79

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹436 Cr	₹254 Cr	₹198 Cr	₹158 Cr	₹118 Cr	₹107 Cr
Total Liabilities	₹239 Cr	₹97 Cr	₹76 Cr	₹66 Cr	₹49 Cr	₹50 Cr
Equity	₹197 Cr	₹157 Cr	₹123 Cr	₹92 Cr	₹69 Cr	₹57 Cr
Total Debt	₹127 Cr	₹6 Cr	₹7 Cr	₹12 Cr	₹11 Cr	₹10 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹36 Cr	₹31 Cr	₹23 Cr	₹30 Cr	₹19 Cr	₹8 Cr
Investing	₹-36 Cr	₹-14 Cr	₹-19 Cr	₹-22 Cr	₹-6 Cr	₹-15 Cr
Financing	₹118 Cr	₹-7 Cr	₹-2 Cr	₹-1 Cr	₹-8 Cr	₹9 Cr
Free Cash Flow	₹36 Cr	₹31 Cr	₹23 Cr	₹30 Cr	₹19 Cr	₹8 Cr

Shareholding

Promoter 66.73% Institutions 1.2% Public 32.07%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search